Eikon Therapeutics, Inc. (EIKN)Healthcare | Biotechnology | Millbrae, United States | NasdaqGS
11.48 USD
-0.07
(-0.606%) ⇩
(April 21, 2026, 11:09 a.m.
EDT)
Short-term: ★★★★☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 19, 2026, 12:40 a.m. EDT
Biotech volatility play: Eikon Therapeutics trades near 52-week lows despite a massive $382M IPO and recent full enrollment in its stage 4 lung cancer trial, suggesting potential near-term upside from catalysts; however, negative fundamentals (-36% ROA, negative book value) and the -5.4% distance below moving averages indicate high risk for hold dynamics. |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 91.107 |
| Market Cap | 621,510,592 |
| Forward P/E | -2.03 |
| Website | https://eikontx.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.23000002 |
| Address1 | 230 Harriet Tubman Way |
| All Time High | 17.4 |
| All Time Low | 8.58 |
| Ask | 14.77 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 343,450 |
| Average Daily Volume3 Month | 482,735 |
| Average Volume | 482,735 |
| Average Volume10Days | 343,450 |
| Bid | 8.32 |
| Bid Size | 2 |
| Book Value | -286.471 |
| City | Millbrae |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 11.48 |
| Current Ratio | 6.343 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 11.7053 |
| Day Low | 11.3 |
| Debt To Equity | 91.107 |
| Display Name | Eikon Therapeutics |
| Earnings Timestamp End | 1,778,243,400 |
| Earnings Timestamp Start | 1,778,243,400 |
| Ebitda | -295,552,992 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -5.779 |
| Enterprise Value | 1,708,114,304 |
| Eps Current Year | -5.80465 |
| Eps Forward | -5.66454 |
| Eps Trailing Twelve Months | -6.18 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 12.493 |
| Fifty Day Average Change | -1.0130005 |
| Fifty Day Average Change Percent | -0.08108544 |
| Fifty Two Week Change Percent | -23.000002 |
| Fifty Two Week High | 17.4 |
| Fifty Two Week High Change | -5.92 |
| Fifty Two Week High Change Percent | -0.3402299 |
| Fifty Two Week Low | 8.58 |
| Fifty Two Week Low Change | 2.8999996 |
| Fifty Two Week Low Change Percent | 0.3379953 |
| Fifty Two Week Range | 8.58 - 17.4 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,770,301,800,000 |
| Float Shares | 27,524,583 |
| Forward Eps | -5.66454 |
| Forward P E | -2.026643 |
| Free Cashflow | -208,894,752 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 384 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.155 |
| Held Percent Institutions | 0.30565 |
| Implied Shares Outstanding | 54,138,555 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,026-02-05 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Eikon Therapeutics, Inc., operates as a clinical biopharmaceutical company in the United States. It develops medicines to address serious unmet medical needs using a platform that permits precise characterization of protein interactions in living cells. Its products include EIK1001, a systemically administered TLR 7/8 dual-agonist designed to activate innate and adaptive immune anti-tumor responses; EIK1003 and EIK1004, which are selective PARP1 inhibitors in ovarian, breast, prostate, and pancreatic cancers and, specifically with the brain-penetrant; EIK1004 to address brain metastases and primary brain malignancies; EIK1005, a potent WRN helicase inhibitor and anti-tumor agent for MSI-high tumors; and EIK1006, a clinical candidate and next-generation androgen receptor antagonist with activity against multiple clinically emergent variants of androgen receptor. The company was incorporated in 2019 and is based in Millbrae, California. |
| Long Name | Eikon Therapeutics, Inc. |
| Market | us_market |
| Market Cap | 621,510,592 |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_638227772 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -333,644,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 624,217,539 |
| Number Of Analyst Opinions | 5 |
| Open | 11.55 |
| Operating Cashflow | -188,516,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 341 777 0566 |
| Previous Close | 11.55 |
| Price Eps Current Year | -1.9777248 |
| Price Hint | 2 |
| Price To Book | -0.04007386 |
| Profit Margins | 0.0 |
| Quick Ratio | 6.108 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.07000065 |
| Regular Market Change Percent | -0.6060662 |
| Regular Market Day High | 11.7053 |
| Regular Market Day Low | 11.3 |
| Regular Market Day Range | 11.3 - 11.7053 |
| Regular Market Open | 11.55 |
| Regular Market Previous Close | 11.55 |
| Regular Market Price | 11.48 |
| Regular Market Time | 1,776,784,172 |
| Regular Market Volume | 47,924 |
| Return On Assets | -0.36192 |
| Return On Equity | -1.25017 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 54,138,555 |
| Shares Percent Shares Out | 0.0612 |
| Shares Short | 3,313,762 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 1,592,952 |
| Short Name | Eikon Therapeutics, Inc. |
| Short Percent Of Float | 0.0813 |
| Short Ratio | 7.99 |
| Source Interval | 15 |
| State | CA |
| Symbol | EIKN |
| Target High Price | 34.0 |
| Target Low Price | 7.0 |
| Target Mean Price | 25.6 |
| Target Median Price | 29.0 |
| Total Cash | 335,975,008 |
| Total Cash Per Share | 6.206 |
| Total Debt | 257,319,008 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -6.18 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 12.542157 |
| Two Hundred Day Average Change | -1.0621576 |
| Two Hundred Day Average Change Percent | -0.084686995 |
| Type Disp | Equity |
| Volume | 47,924 |
| Website | https://eikontx.com |
| Zip | 94,030 |